Investigating Gait Speed as the Index of Exercise Tolerance in Heart Failure with Preserved Ejection Fraction
-
Masaki Takeyoshi
,
Wakana Togami
,
Kei Hiyama
,
Seiji Takashio
,
Yuichiro Arima
,
Kenichi Tsujita
,
Takeshi Miyamoto
Abstract
Introduction: As an essential factor affecting life prognosis and rehospitalization in patients with chronic heart failure, exercise tolerance is a significant outcome of cardiac rehabilitation. Heart failure with preserved ejection fraction (HFpEF) from reduced diastolic capacity has recently increased among patients with chronic heart failure. This study evaluates the factors indicating exercise tolerance in patients with HFpEF from various perspectives, including cardiac and skeletal muscle functions.
Materials and Methods: The subjects were 31 patients with HFpEF who underwent cardiac rehabilitation. The exercise tolerance was assessed using a 6-min walking test. Physical function, physical activity, body composition test, baseline characteristics, blood data, and echocardiography results were extracted from medical records to identify the indicators of exercise tolerance.
Results: Gait speed significantly differed in exercise tolerance for HFpEF patients (β=0.75, P<0.01). Unlike heart failure with reduced ejection fraction (HFrEF), HFpEF was not significantly different in brain natriuretic peptide levels and cardiac function.
Conclusion: Gait speed indicates exercise tolerance in HFpEF patients; however, its pathological course differs from heart failure with reduced ejection fraction, suggesting that it is poorly related to brain natriuretic peptide, a biomarker for heart failure and cardiac function.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Journal of the American College of Cardiology. 2016; 68(13):1476-1488.[DOI:10.1016/j.jacc.2016.05.011] [PMID]
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. European Heart Journal. 2016; ;37(27):2129-200. [DOI:10.1093/eurheartj/ehw128] [PMID]
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. The New England Journal of Medicine. 2002; 346(11):793-801. [DOI:10.1056/NEJMoa011858] [PMID]
Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Peak VO2 and VE/VCO2 slope in patients with heart failure: A prognostic comparison. American Heart Journal. 2004; 147(2):354-60. [DOI:10.1016/j.ahj.2003.07.014] [PMID]
Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993; 270(14):1702-7. [DOI:10.1001/jama.1993.03510140062030] [PMID]
Higginbotham MB, Morris KG, Conn EH, Coleman RE, Cobb FR. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. The American Journal of Cardiology. 1983; 51(1):52-60. [DOI:10.1016/S0002-9149(83)80010-1] [PMID]
Wilson JR, Martin JL, Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: Role of cardiac pump dysfunction as determined by the effect of dobutamine. The American Journal of Cardiology. 1984; 53(9):1308-15. [DOI:10.1016/0002-9149(84)90085-7] [PMID]
Jondeau G, Katz SD, Zohman L, Goldberger M, McCarthy M, Bourdarias JP, LeJemtel TH. Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure. Circulation. 1992; 86(5)1351-6. [DOI:10.1161/01.CIR.86.5.1351] [PMID]
Izawa KP, Watanabe S, Yokoyama H, Hiraki K, Morio Y, Oka K, et al. Muscle strength in relation to disease severity in patients with congestive heart failure. American Journal of Physical Medicine & Rehabilitation. 2007; 86(11):893-900. [DOI:10.1097/PHM.0b013e318154b592] [PMID]
Clark A, Rafferty D, Arbuthnott K. Relationship between isokinetic muscle strength and exercise capacity in chronic heart failure. International Journal of Cardiology. 1997; 59(2):145-8. [DOI:10.1016/S0167-5273(97)02934-3] [PMID]
Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. Journal of the American College of Cardiology. 1997; 30(7):1758-64. [DOI:10.1016/S0735-1097(97)00381-1] [PMID]
Izawa KP, Watanabe S, Oka K, Hiraki K, Morio Y, Kasahara Y, et al. Relation between physical activity and exercise capacity of ≥5 metabolic equivalents in middle- and older-aged patients with chronic heart failure. Disability and Rehabilitation. 2012; 34(23):2018-24. [DOI:10.3109/09638288.2012.667502] [PMID]
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England Journal of Medicine. 2006; 355(3):251-9. [DOI:10.1056/NEJMoa052256] [PMID]
Pandey A, Parashar A, Kumbhani D, Agarwal S, Garg J, Kitzman D, et al. Exercise training in patients with heart failure and preserved ejection fraction: Meta-analysis of randomized control trials. Circulation. Heart Failur. 2015; 8(1):33-40. [DOI:10.1161/CIRCHEARTFAILURE.114.001615] [PMID]
Kamiya K, Sato Y, Takahashi T, Tsuchihashi-Makaya M, Kotooka N, Ikegame T, et al. Multidisciplinary cardiac rehabilitation and long-term prognosis in patients with heart failure. Circulation. Heart Failure. 2020; 13(10):e006798. [DOI:10.1161/CIRCHEARTFAILURE.119.006798] [PMID]
Dhakal BP, Malhotra R, Murphy RM, Pappagianopoulos PP, Baggish AL, Weiner RB, et al. Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: The role of abnormal peripheral oxygen extraction. Circulation. Heart Failure. 2015; 8(2):286-94. [DOI:10.1161/CIRCHEARTFAILURE.114.001825] [PMID]
Kitzman DW, Nicklas B, Kraus WE, Lyles MF, Eggebeen J, Morgan TM, et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. American Journal of Physiology. Heart and Circulatory Physiology. 2014; 306(9):1364-70. [DOI:10.1152/ajpheart.00004.2014] [PMID]
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal. Cardiovascular Imaging. 2016; 17(12):1321-60. [DOI:10.1093/ehjci/jew082] [PMID]
Andersen OS, Smiseth OA, Dokainish H, Abudiab MM, Schutt RC, Kumar A, et al. Estimating left ventricular filling pressure by echocardiography. Journal of the American College of Cardiology. 2017; 69(15):1937-48. [DOI:10.1016/j.jacc.2017.01.058] [PMID]
Giangregorio ML, Webber CE. Effects of metal implants on whole-body dual-energy x-ray absorptiometry measurements of bone mineral content and body composition. Canadian Association of Radiologists Journal = Journal l'Association Canadienne des Radiologistes. 2003; 54(5):305-9. [PMID]
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine. 2002; 166(1):111-7. [DOI:10.1164/ajrccm.166.1.at1102] [PMID]
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. Journal of the American Medical Directors Association. 2020; 21(3):300-7. [DOI:10.1016/j.jamda.2019.12.012] [PMID]
Cohen JB, Schrauben SJ, Zhao L, Basso MD, Cvijic ME, Li Z, et al. Clinical phenogroups in heart failure with preserved ejection fraction: Detailed phenotypes, prognosis, and response to spironolactone.JACC. Heart Failure. 2020; 8(3):172-84. [DOI:10.1016/j.jchf.2019.09.009] [PMID]
Campbell RT, Jhund PS, Castagno D, Hawkins NM, Petrie MC, McMurray JJ. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? Journal of The American College of Cardiology. 2012; 60(23):2349-56.[DOI:10.1016/j.jacc.2012.04.064] [PMID]
Nagai T, Yoshikawa T, Saito Y, Takeishi Y, Yamamoto K, Ogawa H, et al. Clinical characteristics, management, and outcomes of Japanese patients hospitalized for heart failure with preserved ejection fraction- a report from the Japanese heart failure syndrome with preserved ejection fraction (JASPER) Registry. Circulation Journal : Official Journal of The Japanese Circulation Society. 2018; 82(6):1534-45. [DOI:10.1253/circj.CJ-18-0073] [PMID]
Teramoto K, Teng TK, Chandramouli C, Tromp J, Sakata Y, Lam CS. Epidemiology and clinical features of heart failure with preserved ejection fraction. Cardiac Failure Review. 2022; 8:e27. [DOI:10.15420/cfr.2022.06] [PMID]
Eaton CB, Pettinger M, Rossouw J, Martin LW, Foraker R, Quddus A, et al. Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circulation. Heart Failure. 2016; 9(10):e002883. [DOI:10.1161/CIRCHEARTFAILURE.115.002883] [PMID]
Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, et al. Isosorbide mononitrate in heart failure with preserved ejection fraction. The New England Journal of Medicine. 2015; 373(24):2314-24. [DOI:10.1056/NEJMoa1510774] [PMID]
Udelson JE, Lewis GD, Shah SJ, Zile MR, Redfield MM, Burnett J Jr, et al. Effect of praliciguat on peak rate of oxygen consumption in patients with heart failure with preserved ejection fraction: The CAPACITY HFpEF randomized clinical trial. JAMA. 2020; 324(15):1522-31. [DOI:10.1001/jama.2020.16641] [PMID]
Kanagala P, Arnold JR, Singh A, Chan DCS, Cheng ASH, Khan JN, et al. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach. Plos One. 2020; 15(4):e0232280. [DOI:10.1371/journal.pone.0232280] [PMID]
Kamiya K, Hamazaki N, Matsue Y, Mezzani A, Corrà U, Matsuzawa R, et al. Gait speed has comparable prognostic capability to six-minute walk distance in older patients with cardiovascular disease. European Journal of Preventive Cardiology. 2018; 25(2):212-9. [DOI:10.1177/2047487317735715] [PMID]
Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. Journal of the American College of Cardiology. 2011; 58(3):265-74. [DOI:10.1016/j.jacc.2011.02.055] [PMID]
Yamada M, Kimura Y, Ishiyama D, Nishio N, Abe Y, Kakehi T, et al. Differential characteristics of skeletal muscle in community-dwelling older adults. Journal of the American Medical Directors Association. 2017; 18(9):807.e9-807.e16. [DOI:10.1016/j.jamda.2017.05.011] [PMID]
Kitzman DW, Shah SJ. The HFpEF obesity phenotype: The elephant in the room. Journal of the American College of Cardiology. 2016; 68 (2): 200-3. [DOI:10.1016/j.jacc.2016.05.019] [PMID]
Manini TM, Clark BC. Dynapenia and aging: An update.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2012; 67(1):28-40. [DOI:10.1093/gerona/glr010] [PMID]
Konishi M, Kagiyama N, Kamiya K, Saito H, Saito K, Ogasahara Y, et al. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction. European Journal of Preventive Cardiology. 2021; 28(9):1022-9. [DOI:10.1093/eurjpc/zwaa117] [PMID]
Pandey A, Patel KV, Vaduganathan M, Sarma S, Haykowsky MJ, Berry JD, et al. Physical activity, fitness, and obesity in heart failure with preserved ejection fraction. JACC. Heart Failure. 2018; 6(12):975-82. [DOI:10.1016/j.jchf.2018.09.006] [PMID]
| Files | ||
| Issue | Vol 18 No 1 (2024) | |
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/jmr.v18i1.14734 | |
| Keywords | ||
| Exercise tolerance Gait speed Heart failure | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
